Consultant Endocrinologist, Department of Endocrinology; Corresponding Author.
Senior Medical Officer and Academic Registrar, Apollo Excelcare Hospital, Guwahati, Assam.
J Assoc Physicians India. 2023 Aug;71(8):11-12. doi: 10.59556/japi.71.0323.
Insulin therapy is mostly advised in patients with poorly controlled type 2 diabetes mellitus (T2DM). However, wide variation exists in insulin practice and usage across the Indian geography.
In this cross-sectional study, a retrospective audit of the medical records of T2DM patients who were receiving insulin and attending an urban referral clinic in Northeast India during the period from 2006 to 2017 was conducted to analyze the insulin utilization pattern and injection technique variation. A total of 1,454 patients were included, 60% were male and 40% were female.
At presentation, the mean duration of T2DM was 12.13 (7.45) years. Insulin with or without oral anti-diabetic (OADs) was received by 52.27% and 47.73% of patients, respectively. The majority (62.93%) used a pen device for insulin administration. The patient-reported reasons for insulin therapy initiation were OAD failure (33.15%), glucotoxicity (30.26%) and diabetesassociated complications (20.36%). The mean ± standard deviation (SD) total daily dose (TDD) of insulin was 33.05 ± 17.09 (0.53 ± 0.30 units/kg/day). The breakup for the number of injection(s) per day was one (234,16.09%), two (970,66.71%), three (166,11.42%), four (78, 5.36%), and five (6, 0.41%). The majority (67.88%) used premixed insulin, while 10.90% used basal insulin alone. Compared to those without lipohypertrophy (LH), patients with LH were less likely to rotate the site of injection (0.85 vs 17.90%; p = 0.000), space the injections (10.71 vs 23.91%; p = 0.000), injected less often in correct site (7.81 vs 29.0%; p = 0.000), more likely to use wrong angles (10.08 vs 22.73%; p = 0.000) and reuse the needles (5.63 vs 14.86%; p = 0.000). Also, 34.87% of patients were not storing their insulin device at the right temperature and 8.87% experienced at least one episode of a hypoglycemic event.
This audit depicts important attributes of current injection practices amongst T2DM patients on insulin and suggests the possible benefits of adopting correct practices for avoiding complications such as LH and hypoglycemia.
胰岛素治疗主要适用于血糖控制不佳的 2 型糖尿病(T2DM)患者。然而,在印度各地,胰岛素的应用和使用存在很大差异。
在这项回顾性研究中,对 2006 年至 2017 年期间在印度东北部一家城市转诊诊所接受胰岛素治疗的 T2DM 患者的病历进行了回顾性审核,以分析胰岛素的使用模式和注射技术差异。共纳入 1454 例患者,其中 60%为男性,40%为女性。
患者 T2DM 的平均病程为 12.13(7.45)年。分别有 52.27%和 47.73%的患者接受胰岛素联合或不联合口服降糖药(OAD)治疗。大多数(62.93%)患者使用笔式注射器进行胰岛素给药。患者报告开始胰岛素治疗的原因是 OAD 失败(33.15%)、糖毒性(30.26%)和糖尿病相关并发症(20.36%)。胰岛素的平均日总剂量(TDD)为 33.05±17.09(0.53±0.30 单位/公斤/天)。每日注射次数的分布为:1 次(234 例,16.09%)、2 次(970 例,66.71%)、3 次(166 例,11.42%)、4 次(78 例,5.36%)和 5 次(6 例,0.41%)。大多数(67.88%)患者使用预混胰岛素,而 10.90%患者单独使用基础胰岛素。与无脂肪增生(LH)的患者相比,有 LH 的患者不太可能轮换注射部位(0.85%对 17.90%;p=0.000)、间隔注射(10.71%对 23.91%;p=0.000)、较少在正确部位注射(7.81%对 29.0%;p=0.000)、更有可能使用错误的注射角度(10.08%对 22.73%;p=0.000)和重复使用针头(5.63%对 14.86%;p=0.000)。此外,34.87%的患者胰岛素未储存在正确的温度下,8.87%的患者至少经历过一次低血糖事件。
本次审查描述了 T2DM 患者胰岛素治疗的当前注射实践的重要特征,并提示了采用正确实践的可能益处,以避免脂肪增生和低血糖等并发症。